Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis

Jean-Philippe Ranjeva1, Bertrand Audoin, My Van Au Duong

  • 1Centre de Résonance Magnétique Biologique et Médicale, CRMBM UMR CNRS 6612, Faculté de Médecine, 27 Boulevard Jean Moulin 13385 Marseilles cedex 05, France. jp.ranjeva@medecine.univ-mrs.fr

Insights

Subtle cognitive impairment in early multiple sclerosis (MS) is multifactorial, influenced by white matter damage, lesion location, and brain connectivity. A multiregression model using MRI parameters accurately predicts Paced Auditory Serial Addition Test (PASAT) scores, explaining 90% of variance.

Area of Science:

  • Neuroimaging
  • Neurology
  • Cognitive Science

Background:

  • Early multiple sclerosis (MS) can present with subtle cognitive impairments, particularly affecting attention and working memory.
  • Parametric MRI techniques have shown promise in characterizing brain changes in early MS.

Purpose of the Study:

  • To identify structural and functional MRI correlates of cognitive deficits in patients with clinically isolated syndrome suggestive of MS.
  • To develop a predictive model for cognitive performance using multimodal MRI parameters.

Main Methods:

  • Utilized T(2)-weighted MRI, magnetization transfer ratio (MTR) imaging, and functional MRI (fMRI) in 18 patients.
  • Assessed cognitive function using the Paced Auditory Serial Addition Test (PASAT).
  • Employed a multiregression model incorporating independent MRI parameters.

Main Results:

  • Cognitive impairment in early MS is multifactorial, influenced by diffuse white matter damage, lesion location, white matter connectivity, and cortical reorganization.
  • A multiregression model combining MRI parameters explained 90% of the variance in PASAT scores.
  • Individual MRI parameters showed limited influence on PASAT performance.

Conclusions:

  • Accurate monitoring of early cognitive deficits in MS requires consideration of multiple tissue and functional brain pathologies.
  • These findings support the integration of multimodal MRI in evaluating therapeutic strategies for early cognitive impairment in MS.